Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ED.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CQ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.43NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.38.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.19.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.43NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.214NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.284NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.351.3 (Beta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.318NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
R.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.29 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ML.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.283NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.96NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
L.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.407NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.423NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.281NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.230NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.535NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.564.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.345NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.450NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.334NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.589NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.335NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.169NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.43NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.42NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.442NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used